143 related articles for article (PubMed ID: 27859466)
1. The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma.
Cañueto J; Cardeñoso-Álvarez E; Cosano-Quero A; Santos-Briz Á; Fernández-López E; Pérez-Losada J; Román-Curto C
J Cutan Pathol; 2017 Feb; 44(2):144-151. PubMed ID: 27859466
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin expression in cutaneous squamous cell carcinomas and its relationship to histopathological prognostic factors.
Gülseren D; Gököz Ö; Karahan S; Karaduman A
J Histotechnol; 2020 Sep; 43(3):147-152. PubMed ID: 32496961
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression.
Hesse K; Satzger I; Schacht V; Köther B; Hillen U; Klode J; Schaper K; Gutzmer R
Dermatology; 2016; 232(5):558-565. PubMed ID: 27875814
[TBL] [Abstract][Full Text] [Related]
4. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
[TBL] [Abstract][Full Text] [Related]
6. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
[TBL] [Abstract][Full Text] [Related]
7. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk.
Toll A; Gimeno-Beltrán J; Ferrandiz-Pulido C; Masferrer E; Yébenes M; Jucglà A; Abal L; Martí RM; Sanmartín O; Baró T; Casado B; Gandarillas A; Barranco C; Costa I; Mojal S; García-Patos V; Pujol RM
J Am Acad Dermatol; 2012 Dec; 67(6):1310-8. PubMed ID: 22521203
[TBL] [Abstract][Full Text] [Related]
8. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
[TBL] [Abstract][Full Text] [Related]
10. Understanding patterns of invasion: a novel approach to assessment of podoplanin expression in the prediction of lymph node metastasis in oral squamous cell carcinoma.
Sharma A; Boaz K; Natarajan S
Histopathology; 2018 Mar; 72(4):672-678. PubMed ID: 29023936
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C.
Kim HY; Rha KS; Shim GA; Kim JH; Kim JM; Huang SM; Koo BS
Oncol Rep; 2015 Aug; 34(2):833-42. PubMed ID: 26081937
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma.
Chen MK; Cai MY; Luo RZ; Tian X; Liao QM; Zhang XY; Han JD
Br J Dermatol; 2015 Jan; 172(1):111-9. PubMed ID: 24975674
[TBL] [Abstract][Full Text] [Related]
13. High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma.
Suzuki H; Onimaru M; Koga T; Takeshita M; Yano T; Maehara Y; Nakamura S; Sueishi K
Pathol Res Pract; 2011 Feb; 207(2):111-5. PubMed ID: 21194851
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma.
Cañueto J; Cardeñoso-Álvarez E; García-Hernández JL; Galindo-Villardón P; Vicente-Galindo P; Vicente-Villardón JL; Alonso-López D; De Las Rivas J; Valero J; Moyano-Sanz E; Fernández-López E; Mao JH; Castellanos-Martín A; Román-Curto C; Pérez-Losada J
Br J Dermatol; 2017 Jul; 177(1):168-178. PubMed ID: 27943259
[TBL] [Abstract][Full Text] [Related]
15. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
Parhar S; Kaur H; Vashist A; Verma S
Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin Expression Is Correlated With the Progression of Chronic Discoid Lupus Erythematosus to Lip Squamous Cell Carcinoma.
Gao X; Ma L; Zhou Z; Jian X; Liu W
Int J Surg Pathol; 2016 Oct; 24(7):595-9. PubMed ID: 27240861
[TBL] [Abstract][Full Text] [Related]
17. Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma.
Cañueto J; Martín-Vallejo J; Cardeñoso-Álvarez E; Fernández-López E; Pérez-Losada J; Román-Curto C
Clin Exp Dermatol; 2018 Dec; 43(8):876-882. PubMed ID: 29756221
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
[TBL] [Abstract][Full Text] [Related]
19. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.
Tong L; Yuan S; Feng F; Zhang H
Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
